XRAY - DENTSPLY SIRONA Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
56.67
-0.33 (-0.58%)
At close: 4:00PM EDT

56.67 0.00 (0.00%)
After hours: 5:19PM EDT

Stock chart is not supported by your current browser
Previous Close57.00
Open57.12
Bid56.68 x 800
Ask58.82 x 800
Day's Range56.67 - 57.14
52 Week Range33.93 - 59.40
Volume905,031
Avg. Volume1,652,887
Market Cap13.26B
Beta (3Y Monthly)0.73
PE Ratio (TTM)N/A
EPS (TTM)-4.72
Earnings DateAug 2, 2019
Forward Dividend & Yield0.35 (0.61%)
Ex-Dividend Date2019-06-27
1y Target Est59.23
Trade prices are not sourced from all markets
  • Analytical Instruments to Aid Thermo Fisher (TMO) Q2 Earnings?
    Zacks9 hours ago

    Analytical Instruments to Aid Thermo Fisher (TMO) Q2 Earnings?

    Solid global demand, substantial impact from the electron microscopy business and robust volume growth and productivity are likely to favor Thermo Fisher's (TMO) analytical instruments revenues.

  • What's in the Offing for Cerner's (CERN) Earnings in Q2?
    Zacks10 hours ago

    What's in the Offing for Cerner's (CERN) Earnings in Q2?

    Top-line growth and solid show by Population Health, Revenue Cycle and IT Works are likely to aid Cerner's (CERN) Q2 earnings. However, expected decline in bookings is likely to be a dampener.

  • What's in Store for Varian Medical (VAR) in Q3 Earnings?
    Zacks10 hours ago

    What's in Store for Varian Medical (VAR) in Q3 Earnings?

    Probable revenue growth in APAC and EMEA regions and higher Oncology revenues are likely to aid Varian Medical (VAR) in Q3 earnings. However, contraction in margins might be a dampener.

  • What's in Store for Align Technology (ALGN) in Q2 Earnings?
    Zacks11 hours ago

    What's in Store for Align Technology (ALGN) in Q2 Earnings?

    Align Technology (ALGN) is expected to deliver a strong second quarter on continued adoption of Invisalign system.

  • Intuitive Surgical (ISRG) Q2 Earnings Beat, Guidance Narrowed
    Zacks11 hours ago

    Intuitive Surgical (ISRG) Q2 Earnings Beat, Guidance Narrowed

    Intuitive Surgical (ISRG) expects 2019 procedure growth within 16-17%.

  • Will 2-Pronged Plan Aid Quest Diagnostics (DGX) Q2 Earnings?
    Zacksyesterday

    Will 2-Pronged Plan Aid Quest Diagnostics (DGX) Q2 Earnings?

    Quest Diagnostics' (DGX) frequent partnership wins with health care leaders and sensible buyouts are creating bountiful opportunities for the top and the bottom line.

  • BioTelemetry (BEAT) to Report Q2 Earnings: What's in Store?
    Zacksyesterday

    BioTelemetry (BEAT) to Report Q2 Earnings: What's in Store?

    BioTelemetry's (BEAT) strong second-quarter 2019 expectations are indicative of solid results.

  • What's in Store for Edwards Lifesciences' (EW) Q2 Earnings?
    Zacksyesterday

    What's in Store for Edwards Lifesciences' (EW) Q2 Earnings?

    Edwards Lifesciences (EW) is likely to deliver a solid second quarter on robust segmental performance.

  • Here's Why Investors Should Consider Cerner (CERN) Stock
    Zacksyesterday

    Here's Why Investors Should Consider Cerner (CERN) Stock

    For the second quarter, Cerner (CERN) expects revenues between $1.41 billion and $1.46 billion.

  • Falling Earnings Estimates Signal Weakness Ahead for Patterson Companies (PDCO)
    Zacksyesterday

    Falling Earnings Estimates Signal Weakness Ahead for Patterson Companies (PDCO)

    Patterson Companies (PDCO) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

  • 7 S&P 500-Beating Stocks to Buy Ahead of Q2 Earnings
    Zacks2 days ago

    7 S&P 500-Beating Stocks to Buy Ahead of Q2 Earnings

    Here we pick seven stocks that have outperformed the S&P 500 and are likely to beat earnings estimates this reporting cycle.

  • Can Global Industrial Unit Drive Ecolab's (ECL) Q2 Earnings?
    Zacks3 days ago

    Can Global Industrial Unit Drive Ecolab's (ECL) Q2 Earnings?

    Ecolab (ECL) likely to see impressive growth in second-quarter adjusted earnings per share.

  • Will Abbott's (ABT) Q2 Earnings Gain From Overall Growth?
    Zacks4 days ago

    Will Abbott's (ABT) Q2 Earnings Gain From Overall Growth?

    Abbott's (ABT) consistent rise on a strong Diabetes Care business performance is seen over the last few quarters.

  • McKesson (MCK) to Report Q1 Earnings: What's in the Offing?
    Zacks4 days ago

    McKesson (MCK) to Report Q1 Earnings: What's in the Offing?

    Top-line growth and better-than-expected segmental performance are likely to aid McKesson (MCK) in Q1. However, rise in adjusted operating expenses is likely to be a dampener.

  • Can Instruments Drive Intuitive Surgical (ISRG) Q2 Earnings?
    Zacks7 days ago

    Can Instruments Drive Intuitive Surgical (ISRG) Q2 Earnings?

    Intuitive Surgical (ISRG) expects its core Instruments and Accessories unit to boost second-quarter 2019 results.

  • GlobeNewswire8 days ago

    Dentsply Sirona to Host Second Quarter 2019 Conference Call on August 2nd

    CHARLOTTE, N.C., July 11, 2019 -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and.

  • AngioDynamics (ANGO) Q4 Earnings Miss, Revenues Top Estimates
    Zacks8 days ago

    AngioDynamics (ANGO) Q4 Earnings Miss, Revenues Top Estimates

    AngioDyamics (ANGO) gains from solid segmental contributions in fourth-quarter fiscal 2019.

  • Markit10 days ago

    See what the IHS Markit Score report has to say about DENTSPLY SIRONA Inc.

    DENTSPLY SIRONA Inc NASDAQ/NGS:XRAYView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for XRAY with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting XRAY. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.98 billion over the last one-month into ETFs that hold XRAY are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Barrons.com11 days ago

    Cardinal Health Stock Dips on News of Departure of CFO Jorge Gomez

    Monday started with a jolt for investors in the pharmaceutical distributor, which announced in a regulatory filing that longtime Chief Financial Officer Jorge Gomez is leaving the company.

  • MarketWatch11 days ago

    Dentsply Sirona says Cardinal Health CFO Jorge Gomez to become its CFO

    Dental products maker Dentsply Sirona Inc. said Monday it has appointed Jorge Gomez, former chief financial officer of Cardinal Health Inc. as its CFO. The announcement came shortly after Cardinal Health said Gomez was leaving on Aug. 9. Dentsply shares were not active premarket, but have gained 55% in 2019, while the S&P 500 has gained 19.3%.

  • GlobeNewswire11 days ago

    Dentsply Sirona Announces Appointment of Jorge M. Gomez as Chief Financial Officer

    DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (XRAY), the Dental Solutions Company, today announced the appointment of Jorge M. Gomez as Chief Financial Officer. Jorge M. Gomez served as Chief Financial Officer of Cardinal Health since January 2018, where he was responsible for financial activities across the enterprise, including financial strategy, capital deployment, treasury, investor relations, tax, accounting and external reporting.  Prior to that, Jorge was Chief Financial Officer of the Medical and Pharmaceutical segments, and Treasurer and Corporate Controller at Cardinal Health.  Before joining Cardinal Health, Jorge held multiple executive and leadership roles at General Motors and the Smurfit-Kappa Group. "On behalf of the entire management team, I would like to extend a warm welcome to Jorge Gomez.  He is a talented global executive with an in-depth knowledge of the healthcare market, who brings the right mix of skills and experience, and a solid track record of successfully managing global finance operations,” said Don Casey, Dentsply Sirona’s CEO.

  • Smith & Nephew Acquires Atracsys, Expands Robotic Portfolio
    Zacks15 days ago

    Smith & Nephew Acquires Atracsys, Expands Robotic Portfolio

    With Smith & Nephew's (SNN) buyout of Atracsys, the latter's fusionTrack 500 optical tracking camera will be a core enabling technology for the company's next-generation robotics platform.

  • Varian to Acquire Boston Scientific's Embolic Bead Products
    Zacks16 days ago

    Varian to Acquire Boston Scientific's Embolic Bead Products

    Varian (VAR) expects the buyout to prove accretive to its fiscal 2020 reported and adjusted earnings per share.

  • Myriad Genetics' Elevate 2020 Plan Holds Promise Amid Issues
    Zacks17 days ago

    Myriad Genetics' Elevate 2020 Plan Holds Promise Amid Issues

    Myriad Genetics (MYGN) unveils an 'Elevate 2020' program that aims to generate $50 million in incremental operating income by fiscal 2020.

  • Medtronic's Titan Spine Buyout to Boost Spine Surgery Range
    Zacks17 days ago

    Medtronic's Titan Spine Buyout to Boost Spine Surgery Range

    Medtronic's (MDT) comprehensive biologics portfolio clubbed with Titan Spine's surface-enhanced titanium implants can enhance patient outcomes in spinal procedures.